The expression and involvement of both CCL2 and its receptor CCR2 have been established in several pathological conditions, including rheumatoid arthritis (3), atherosclerosis (4), multiple sclerosis (5), cancer-induced bone loss (6), and bacterially induced bone loss (7). The gene discussed is CCL2; the disease is rheumatoid arthritis.